newsfilter
← Latest News
GlobeNewswire·

UroGen Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

  • UroGen Pharma Ltd. announced management will present at the Goldman Sachs 47th Annual Global Healthcare Conference from June 8-10, 2026.
  • The specific presentation is scheduled for June 10, 2026, at 8:40 AM ET in Miami Beach, FL, featuring a fireside chat and one-on-one investor meetings.
  • A webcast of the event will be available via a provided link, on UroGen's corporate website under Events & Presentations, with a replay accessible for approximately 90 days.
  • UroGen has developed RTGel, a proprietary reverse-thermal hydrogel platform designed to enable sustained release of medications for longer urinary tract tissue exposure.
  • The company's first product is approved to treat low-grade upper tract urothelial cancer, while its second product is approved for adult patients with recurrent LG-IR-NMIBC.
  • Both approved products are designed to ablate tumors through non-surgical means.
  • UroGen Pharma Ltd. is headquartered in Princeton, NJ, with operations in Israel.